|
CAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.97929999957003E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.50040000044005E-07 |
| Normal-vs-Stage2 |
3.663800E-01 |
| Normal-vs-Stage3 |
1.595550E-04 |
| Normal-vs-Stage4 |
1.417580E-03 |
| Stage1-vs-Stage2 |
1.464250E-02 |
| Stage1-vs-Stage3 |
9.869200E-01 |
| Stage1-vs-Stage4 |
8.933200E-01 |
| Stage2-vs-Stage3 |
4.947600E-02 |
| Stage2-vs-Stage4 |
6.019500E-02 |
| Stage3-vs-Stage4 |
9.227400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.35369999987311E-07 |
| Normal-vs-AfricanAmerican |
6.205700E-04 |
| Normal-vs-Asian |
3.875900E-03 |
| Caucasian-vs-AfricanAmerican |
4.373600E-01 |
| Caucasian-vs-Asian |
5.672200E-01 |
| AfricanAmerican-vs-Asian |
2.524600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.027800E-04 |
| Normal-vs-Female |
5.63319999979939E-07 |
| Male-vs-Female |
4.729800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.02599999946196E-07 |
| Normal-vs-Age(41-60Yrs) |
1.180550E-04 |
| Normal-vs-Age(61-80Yrs) |
1.476080E-02 |
| Normal-vs-Age(81-100Yrs) |
4.983500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.161240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.301440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.664200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.745000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.864800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.952200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.556200E-01 |
| Classical-VS-Follicular |
1.57989954452376E-10 |
| Classical-VS-Other |
1.004650E-01 |
| Classical-VS-Normal |
9.85269976716552E-10 |
| Tall-VS-Follicular |
2.41599999999398E-05 |
| Tall-VS-Other |
1.039200E-01 |
| Tall-VS-Normal |
2.990000E-04 |
| Follicular-VS-Other |
6.383400E-01 |
| Follicular-VS-Normal |
6.994600E-01 |
| Other-VS-Normal |
7.522400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.199700E-03 |
| Normal-vs-N1 |
1.604050E-02 |
| N0-vs-N1 |
5.431600E-01 |
|
|
